Working collaboratively with vulnerable women to identify the best implementation gains by screening cervical cancer more effectively in European countries

acronym: CBIG-SCREEN
start: 2021-03-01
end: 2026-02-28
 
programme: H2020 - Horisont 2020
sub-programme: HEALTH - Tervishoid, demograafilised muutused ja heaolu
instrument: RIA
call identifier: H2020-SC1-2020-Single-Stage-RTD
project number: 964049
duration in months: 60
partner count: 16
 
abstract: CBIG-SCREEN aims to tackle inequality in cervical cancer screening (CCS) continuum. Though CCS programmes drastically reduce cervical cancer mortality, they remain largely inaccessible and underused by subpopulations of vulnerable women, creating inequali
partner no and role partner name country contact person web page
1 coordinator INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR Marc BARDOU www.inserm.fr
2 partner REGION MIDTJYLLAND DK www.rm.dk
3 partner LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER UK
4 partner AZIENDA UNITA SANITARIA LOCALE DI REGGIO EMILIA IT www.ausl.re.it
5 partner INSTITUTO DE SAUDE PUBLICA DA UNIVERSIDADE DO PORTO PT www.ispup.up.pt
6 partner TARTU ULIKOOL EE www.ut.ee
7 partner UNIVERSITATEA BABES BOLYAI RO www.ubbcluj.ro
8 partner INSTITUTUL ONCOLOGIC PROF DR ION CHIRICUTA CLUJ-NAPOCA RO www.iocn.ro
9 partner EUROPEAN INSTITUTE OF WOMEN'S HEALTH COMPANY LIMITED BY GUARANTEE IE www.eurohealth.ie
10 partner CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER FR www.iarc.fr
11 partner ECOLE D'ECONOMIE DE PARIS FR https://www.parisschoolofeconomics.eu/fr/
12 partner NAUCHNO-UZSLEDOVATELSKI CENTRE PSIHOLOGIYA I ZDRAVE FONDATSIYA BG www.healthpsychologycenter.org
13 partner ASSOCIATION EUROPEENNE DES LIGUES CONTRE LE CANCER ASBL BE www.europeancancerleagues.org
14 partner INSERM TRANSFERT SA FR www.inserm-transfert.fr